Nathan Scott

Designed protein logic to target cells with precise combinations of surface antigens

New Blocking Antibodies Impede Adhesion, Migration and Survival of Ovarian Cancer Cells, Highlighting MFGE8 as a Potential Therapeutic Target of Human Ovarian Carcinoma

Role of osteopontin in the pathophysiology of cancer

Targeted glycan degradation potentiates the anticancer immune response in vivo

Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) × c-MET Antibodies and Antibody-Drug Conjugates

Antibody-targeted drugs and drug resistance—Challenges and solutions

CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity

Site-specific antibody drug conjugates for cancer therapy

Extracellular matrix structure

Non-alcoholic fatty liver disease

Direct effects of thyroid hormones on hepatic lipid metabolism

Antibody–drug conjugates: current status and future directions

Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope

Strategies and challenges for the next generation of antibody–drug conjugates

The DNA sequence of equine herpesvirus-1

Generation of a reporter yellow fever virus for high throughput antiviral assays

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

AASLD guidelines for the treatment of hepatocellular carcinoma

Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes

Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials.

International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors

Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box

Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development

Semisynthesis of an Active Enzyme by Quantitative Click Ligation

Practical Considerations, Challenges, and Limitations of Bioconjugation via Azide–Alkyne Cycloaddition

Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer

Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates

Sequence characteristics of a gene in equine herpesvirus 1 homologous to glycoprotein H of herpes simplex virus

Identification and Nucleotide Sequence of a Gene in Equine Herpesvirus 1 Analogous to the Herpes Simplex Virus Gene Encoding the Major Envelope Glycoprotein gB

Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of Dyslipidemia